Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P7
Near historical low
vs 5Y Ago
-5.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -40.63% |
| Q3 2025 | 34.69% |
| Q2 2025 | 14.04% |
| Q1 2025 | -23.91% |
| Q4 2024 | 4.17% |
| Q3 2024 | -17.07% |
| Q2 2024 | 24.07% |
| Q1 2024 | -14.89% |
| Q4 2023 | 7.84% |
| Q3 2023 | -24.39% |
| Q2 2023 | 48.75% |
| Q1 2023 | -116.33% |
| Q4 2022 | 800.00% |
| Q3 2022 | 59.77% |
| Q2 2022 | 21.97% |
| Q1 2022 | -2.29% |
| Q4 2021 | 0.46% |
| Q3 2021 | 26.26% |
| Q2 2021 | -27.47% |
| Q1 2021 | 11.41% |
| Q4 2020 | 8.04% |
| Q3 2020 | -20.68% |
| Q2 2020 | 34.89% |
| Q1 2020 | -116.67% |
| Q4 2019 | -9.80% |
| Q3 2019 | -22.40% |
| Q2 2019 | -28.87% |
| Q1 2019 | 0.00% |